{"id":"W2946781777","doi":"10.1016/j.conctc.2019.100385","title":"Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial","year":2019,"lang":"en","type":"article","venue":"Contemporary Clinical Trials Communications","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baycrest Hospital; Health Sciences Centre; Canada Research Chairs; University of Toronto; Sunnybrook Health Science Centre","funders":"Networks of Centres of Excellence of Canada; Canadian Institutes of Health Research; National Institutes of Health; Fondation Brain Canada; W. Garfield Weston Foundation; Alzheimer Society; Québec Consortium for Drug Discovery; Fondation Leducq; Scottish Rite Charitable Foundation of Canada; California HIV/AIDS Research Program; ALS Society of Canada; National Institute on Aging; Alzheimer's Association; Consortium canadien en neurodégénérescence associée au vieillissement; Alzheimer's Drug Discovery Foundation","keywords":"Clinical Global Impression; Medicine; Randomized controlled trial; Clinical trial; Brief Pain Inventory; Placebo; Chronic pain; Physical therapy; Psychology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0212164,0.00663633,0.01250436,0.001844459,0.003119136,0.003501015,0.003548278,0.0080113,0.03958067],"category_scores_gemma":[0.01826548,0.002751394,0.005348685,0.002654542,0.003415732,0.003609263,0.001663201,0.007460015,0.008814946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003018287,"about_ca_system_score_gemma":0.01158982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001687127,"about_ca_topic_score_gemma":0.004528088,"domain_scores_codex":[0.9895564,0.005269486,0.00123454,0.001105342,0.001328474,0.001505733],"domain_scores_gemma":[0.9907162,0.001983589,0.002111985,0.00103084,0.002118234,0.002039022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9597275,0.01500779,0.0003636043,0.005724635,0.001150955,0.0001043152,0.0001234428,0.0006888751,0.00213082,0.0007726846,0.003653343,0.01055192],"study_design_scores_gemma":[0.9605981,0.02970132,0.0009344811,0.000493203,0.0004857279,0.00002228352,0.0000297629,0.0005723094,0.0003522813,0.0005415402,0.006226957,0.00004202765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.007693524,0.0007927968,0.001284926,0.0002314653,0.0004817375,0.9871901,0.001103558,0.0001471679,0.001074737],"genre_scores_gemma":[0.008082852,0.00055876,0.002190698,0.0003860635,0.0001555486,0.9874258,0.0003118744,0.00001312599,0.0008753289],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.03958067,"threshold_uncertainty_score":0.1324105,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2415019245825406,"score_gpt":0.5149623304461717,"score_spread":0.2734604058636311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}